Alere launches rapid malaria test

|About: Alere Inc. (ALR)|By:, SA News Editor

Point-of-care diagnostics firm Alere (ALR +0.1%) announces the commercial launch of the Alere Malaria Ag P.f., a rapid blood screening test for malaria infection in asymptomatic people.

The test detects histidine-rich protein II antigen of Plasmodium falciparum malaria in human whole blood within 20 minutes. The company says it has more than 10x better sensitivity than other rapid tests with a shorter turnaround time.